Marinus Pharmaceuticals: Q1 Earnings Snapshot

RADNOR, Pa. (AP) — RADNOR, Pa. (AP) — Marinus Pharmaceuticals Inc. (MRNS) on Wednesday reported a loss of $38.7 million in its first quarter.

On a per-share basis, the Radnor, Pennsylvania-based company said it had a loss of 68 cents.

The results met Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for a loss of 68 cents per share.

The epilepsy drug developer posted revenue of $7.7 million in the period, which fell short of Street forecasts. Five analysts surveyed by Zacks expected $8.6 million.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on MRNS at

Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

Federal News Network Logo
Log in to your WTOP account for notifications and alerts customized for you.

Sign up